OBI Pharma Inc (台灣浩鼎) chairman Michael Chang (張念慈) was yesterday morning released after posting NT$1 million (US$30,914) bail, as prosecutors listed him as a defendant on insider trading charges.
Chang and four other OBI Pharma executives were summoned for questioning at the Shilin District Prosecutors’ Office in Taipei on Friday, after judicial investigators searched the company headquarters and its laboratories to gather evidence earlier that day.
Prosecutors said they had made breakthroughs in the investigation and therefore questioned the other four company executives, including OBI Pharma general manager Huang Hsiu-mei (黃秀美), head of research and development Yu Cheng-te (游丞德), administration division manager Liao Tsung-chih (廖宗智) and finance division manager Chang Sui-fen (張穗芬), to gather information related to the case.
Photo: Wang Yi-sung, Taipei Times
Prosecutors said there is sufficient evidence of their involvement in insider trading to list them as defendants in the case, but they were released without bail yesterday.
OBI Pharma yesterday issued a statement, saying the company did not engage in any illegal activities, and asked the justice agencies to conduct a fair and unbiased investigation to clear the company of the charges.
The statement criticized the search process, with judicial investigators confiscating private documents and material containing proprietary business information, some of which relates to the company’s core technology development, including results of more than 10 years of research, which it said would adversely affect the rights of company shareholders if leaked and deal a severe blow to the nation’s pharmaceutical, healthcare and bioscience industries.
Academia Sinica President Wong Chi-huey (翁啟惠), a prominent Taiwanese-American biochemist and research scientist, has also been embroiled in the affair.
He returned to Taiwan from the US on Friday and met with President Ma Ying-jeou (馬英九) to discuss the case; he again apologized to the public for the controversy, saying he was not involved in insider trading and had no intention of manipulating OBI Pharma shares, some of which were held in his daughter’s name.
While he was in the US, Wong tendered his resignation on March 31, but Ma rejected it.
In related news, Academia Sinica yesterday settled on three candidates for its next president, with the list to be forwarded to the Presidential Office for selection, Academia Sinica Vice President Wang Fan-sen (王汎森) said.
Additional reporting by Wu Po-wei
TPP RALLY: The clashes occurred near the Chiang Kai-shek Memorial Hall on Saturday at a rally to mark the anniversary of a raid on former TPP chairman Ko Wen-je People who clashed with police at a Taiwan People’s Party (TPP) rally in Taipei on Saturday would be referred to prosecutors for investigation, said the Ministry of the Interior, which oversees the National Police Agency. Taipei police had collected evidence of obstruction of public officials and coercion by “disorderly” demonstrators, as well as contraventions of the Assembly and Parade Act (集會遊行法), the ministry said in a statement on Sunday. It added that amid the “severe pushing and jostling” by some demonstrators, eight police officers were injured, including one who was sent to hospital after losing consciousness, allegedly due to heat stroke. The Taipei
NO LIVERPOOL TRIP: Taiwan’s Lin Yu-ting, who won a gold medal in the boxing at the Paris Olympics, was embroiled in controversy about her gender at that event Taiwanese boxer Lin Yu-ting (林郁婷) will not attend this year’s World Boxing Championships in Liverpool, England, due to a lack of response regarding her sex tests from the organizer, World Boxing. The national boxing association on Monday said that it had submitted all required tests to World Boxing, but had not received a response as of Monday, the departure day for the championships. It said the decision for Lin to skip the championships was made to protect its athletes, ensuring they would not travel to the UK without a guarantee of participation. Lin, who won a gold medal in the women’s 57kg boxing
‘NOT ALONE’: A Taiwan Strait war would disrupt global trade routes, and could spark a worldwide crisis, so a powerful US presence is needed as a deterrence, a US senator said US Senator Deb Fischer on Thursday urged her colleagues in the US Congress to deepen Washington’s cooperation with Taiwan and other Indo-Pacific partners to contain the global security threat from China. Fischer and other lawmakers recently returned from an official trip to the Indo-Pacific region, where they toured US military bases in Hawaii and Guam, and visited leaders, including President William Lai (賴清德). The trip underscored the reality that the world is undergoing turmoil, and maintaining a free and open Indo-Pacific region is crucial to the security interests of the US and its partners, she said. Her visit to Taiwan demonstrated ways the
The US has revoked Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) authorization to freely ship essential gear to its main Chinese chipmaking base, potentially curtailing its production capabilities at that older-generation facility. American officials recently informed TSMC of their decision to end the Taiwanese chipmaker’s so-called validated end user (VEU) status for its Nanjing site. The action mirrors steps the US took to revoke VEU designations for China facilities owned by Samsung Electronics Co and SK Hynix Inc. The waivers are set to expire in about four months. “TSMC has received notification from the US Government that our VEU authorization for TSMC Nanjing
RSS